Martin Laudenbach Strengthens Remora's Board as New Chair
Portfolio - People | Feb 17, 2025 | EOS Investment Management Limited (Eos Advisory)
Remora, an innovator in sustainable biofilm prevention technology, has appointed Martin Laudenbach as its new independent director and Chair. The technology, inspired by red seaweed and developed in collaboration with Unilever and UK universities, offers a non-toxic alternative to traditional antibacterial agents. Laudenbach, with over 30 years of experience in the chemical industry at BASF and Solvay, brings vast expertise to Remora as the company expands its technology across healthcare, coatings, textiles, and more. Laudenbach is expected to guide Remora's strategic growth and development, leveraging his international experience and leadership skills to propel the company towards increased global success. Remora's CEO, Dr. Richard Hammond, expresses confidence in Laudenbach's appointment, emphasizing his alignment with the company's mission of innovation and sustainability.
Sectors
- Biotechnology
- Chemicals
- Sustainability
Geography
- United Kingdom – Remora's technology development is backed by collaborative support from UK universities and research bodies.
- Germany – Martin Laudenbach is currently based in Frankfurt, and brings a global perspective from his international roles.
Industry
- Biotechnology – The article focuses on Remora's advanced biofilm prevention technology, an innovation within the biotech industry.
- Chemicals – Martin Laudenbach's background in the chemical industry with companies like BASF and Solvay is relevant to the article.
- Sustainability – Remora's emphasis on sustainable, non-toxic solutions highlights its involvement in the sustainability sector.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Remora | Target Company | Company | A leader in sustainable biofilm prevention technology. |
| Martin Laudenbach | Chair | Person | Appointed as Chair for Remora, brings extensive experience in global business and chemical industry. |
| EOS Investment Management Limited (Eos Advisory) | Private Equity Firm | Company | Backers of Remora, supporting innovation and sustainable practices. |
| Unilever | Collaborative Partner | Company | Collaborated with Remora in the development of its biofilm prevention technology. |
| Dr Richard Hammond | CEO | Person | CEO of Remora, instrumental in guiding company growth and innovation. |
| UK Universities and Research Bodies | Support Partner | Organization | Provided research support for the development of Remora's technology. |